Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
A spotlight on some of the most exciting glycomics innovations from the past year.
GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.
GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.
This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.
A network serving the field of glycomics research provides a platform for connections and funding
Thanks to a large donation and the work of GlycoNet researcher and UdeM biochemist Alexey Pshezhetsky, the Elisa Linton Research Chair in Lysosomal Diseases will help treat Sanfilippo disease and similar genetic syndromes.
This investment will support state-of-the-art glycomics research that focuses on different aspects of One Health—human, animal and environmental health.
Janice Bailey, Jason Acker and Louise St-Onge have joined the GlycoNet Board of Directors
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.